OBJECTIVES

To create a pilot urologic malignancy registry using demographic and clinical data of a cohort of patients newly diagnosed to have urologic malignancies in the year 2021.

METHODS

This was a prospective cohort study conducted in four study sites: National Kidney and Transplant Institute, East Avenue Medical Center, UP-Philippine General Hospital and Batangas Medical Center

RESULTS

A total of 243 patients with newly diagnosed urologic cancers were enrolled. The median age was 61 years, with a wide range of 1 to 87 years. Most of the patients (81.47%) were male, while there were 45 females (18.52%) who had either urinary bladder, kidney or upper urothelial cancer. The most common type of malignancy was prostate cancer (34.57%), followed by kidney cancer (30.04%) and urinary bladder cancer (24.69%), consistent with the currently observed worldwide incidence. There were also 3 patients (1.23%) noted with multiple primaries. More than half of the patients (63.37%) received surgery as active treatment. After the two-year follow-up period, thirteen patients (5.35%) developed progressive disease, and 14 patients (5.76%) died.

CONCLUSION

This urologic cancer registry represents the first multi-center, investigator-initiated epidemiologic study of its kind in the Philippines. As a proof-of-concept (POC) project, it demonstrates the feasibility of establishing a national database capturing baseline data on the country’s most common urologic malignancies.

Cohort Studies ; Multiple Chronic Conditions ; Prostatic Neoplasms ; General Surgery ; Epidemiology

Objectives: To identify practice variations among adult urologists in the surgical management of their oncologic cases and postoperative complications. Methods: Beginning March 2022 to October 2022 an internet-based survey was performed among members of the PUA practicing in the Philippines. Results: 82 Philippine urologists answered the survey during the study period. Majority have no subspecialty training (n=42) and practice primarily in the NCR (n=49). Open radical prostatectomy is the option of choice (n=58) with reported incidence of complications similar to that of previous studies. Conduit (n=77) is the diversion of choice after radical cystectomy with the majority recommending a two-surgeon approach in the harvest and reconstruction. Conclusion Practice is focused within the NCR with the majority having no subspecialty training thus preferring open surgical approach and two-surgeon team. Implantable devices are the preferred method in managing erectile dysfunction and urinary incontinence but is still lacking local availability.

INTRODUCTION AND OBJECTIVES: Laparoscopic adrenalectomy is the standard treatment for adrenal tumors.Described here is the authors’ 10-year experience with laparoscopic adrenalectomy in a single center. METHODS: A retrospective chart review was done on all patients who underwent laparoscopicadrenalectomy from January 2006 to January 2016 at the National Kidney and Transplant Institute.The authors determined the patient demographics (age and gender), tumor characteristics (size,functionality and laterality) and surgical outcomes (operative time, estimated blood loss, conversionto open and complications according to the Clavien-Dindo classification). RESULTS: A total of 90 patients underwent laparoscopic adrenalectomy. The female to male ratio was1.4:1. Most tumors were left-sided [48/90 (53%)], with a mean size of 3.0 ± 0.75cm. The operativetime was 145 ± 35 minutes. The mean estimated blood loss was 50 ± 100cc. The length of hospitalstay was 3.0 ± 1 days. Forty six percent (42/90) of the adrenals were functioning: Hyperaldosteronism(26), Pheochromocytoma (14), and Cushing's syndrome (2). Ninety eight percent(88/90) were benign. There were 2 (2.2%) conversions to open. There were 8 complications (8.89%)(all Dindo-Clavien Class II), all of which were managed conservatively. There was no mortality. CONCLUSION The authors’ experience with laparoscopic adrenalectomy shows that it is safe and effectivefor adrenal tumors.
Laparoscopy

BACKGROUND: Adrenal  nodules  can  either  be  non  functioning or hormone secreting. Once proven functional,
adrenalectomy is warranted. Laparoscopic adrenalectomy has been the popular intervention for these nodules. There is no local literature citing the clinical outcomes, particularly on  symptom  and  medication  reduction.  Considering  that  these tumors present with hypertension, such condition may be  under  diagnosed  in  a  population  with  a  hypertension  prevalence  of  22.3%.  This  study  reviewed  the  outcomes 
of the procedure particularly on the improvement of signs and  symptoms  and  medication  use.

METHODOLOGY: This  is  a  retrospective  review  describing  the  post-operative  outcomes  of  patients  who  underwent  laparoscopic  adrenalectomy  conducted  in  a  tertiary 
medical  center  from  2010  -  2015. 

RESULTS: Twenty-three  (23)  patients  were  categorized  according  to  pathology  -  primary  hyperaldosteronism 
-(17),   pheochromocytoma   -   four  (4)  and  Cushing's  syndrome - two (2). Post-operatively, there was a reduction in  the  systolic  blood  pressure  of  patients  with  primary  hyperaldosteronism  (p  =  0.156).  A  mean  reduction  of  20-30  mmHg  in  the  blood  pressure  was  documented  in patients  who  had  pheochromocytoma  (p  =  0.625).  There  was  a  reduction  in  the  number  and  dosages  of  anti-hypertensive  medications  (primary  hyperaldosteronism  p=
Human ; Male ; Female ; Aged 80 And Over ; Aged (a Person 65 Through 79 Years Of Age) ; Middle Aged (a Person 45-64 Years Of Age) ; Adult (a Perso ; Adrenalectomy ; Antihypertensive Agents ; Pheochromocytoma ; Hydrocortisone ; Hyperaldosteronism ; Hypertension ; Cushing Syndrome ; Blood Pressure Determination